Dare Bioscience Inc. (DARE)
Market Closed
15 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XBER $
2. 28
-0.19
-7.69%
After Hours
$
+0.12 +5.26% 2. 40
17.23M Market Cap
- P/E Ratio
0% Div Yield
478,006 Volume
-0.25 Eps
$ 2.47
Previous Close Day Range
2.26 2.54
Year Range
1.61 9.19
Want to track DARE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript
Daré Bioscience, Inc. (NASDAQ:DARE ) Q2 2024 Earnings Call Transcript August 12, 2024 4:30 PM ET Company Participants MarDee Haring-Layton - CAO Sabrina Martucci Johnson - President and CEO Conference Call Participants Catherine Novack - Jones Research Douglas Tsao - H.C. Wainwright & Co. Operator Welcome to the conference call hosted by Daré Bioscience to review the company's second quarter financial results and to provide a general business update.
Seekingalpha | 1 year ago
Dare Bioscience, Inc. (DARE) Q2 Earnings Top Estimates
Dare Bioscience, Inc. (DARE) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of a loss of $0.57 per share. This compares to loss of $1.20 per share a year ago.
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
